Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls (Q72934120)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6283576%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6283576%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

6

R M Post

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6283576%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

author name string

L. J. Siever

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6283576

16 September 2023

T. W. Uhde

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6283576

16 September 2023

E. K. Silberman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6283576

16 September 2023

D. C. Jimerson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6283576

16 September 2023

J. A. Aloi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6283576

16 September 2023

D. L. Murphy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6283576

16 September 2023

language of work or name

English

0 references

publication date

1 April 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6283576%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

30 October 2019

https://api.elsevier.com/content/article/PII:0165178182900051?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

https://api.elsevier.com/content/article/PII:0165178182900051?httpAccept=text/plain

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

16 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6283576%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6283576%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6283576%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

171-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6283576%20AND%20SRC:MED&resulttype=core&format=json

Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPG

30 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Norepinephrine in depressive reactions. A review

16 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

16 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Neuroendocrine and amine studies in affective illness

16 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Corticosteroid and growth hormone responses to methylamphetamine in depressive illness

16 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Hormone Responses to Methylamphetamine in Depression: a New Approach to the Noradrenaline Depletion Hypothesis

16 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Growth hormone and other responses to clonidine in patients with endogenous depression

16 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Effects of Estrogen and Sex Difference on Secretion of Human Growth Hormone1

16 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Growth-hormone and prolactin response to levodopa in affective illness

16 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Growth Hormone Responses to Hypoglycemia in Postmenopausal Depressed Women

16 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethylene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometry

16 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Reduced growth hormone responses to amphetamine in "endogenous" depressive patients: studies in normal, "reactive" and "endogenous" depressive, schizophrenic, and chronic alcoholic subjects

16 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Pituitary responses to thyrotropin releasing hormone in depressed patients: a review

16 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

A Study of Growth Hormone Release in Depression

16 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

3-Methoxy-4-Hydroxyphenethyleneglycol Production by Human Brain in Vivo

16 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Plasma GH responses to hypothalamic, hippocampal and amygdaloid electrical stimulation: effects of variation in stimulus parameters and treatment with -methyl-p-tyrosine ( -MT).

16 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Effect of clonidine on growth hormone release in psychiatric patients and controls

16 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Growth hormone response in patients with depression

16 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Monoamine metabolism in rat brain regions following long term alcohol treatment

16 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Studies of the Sex Based Variation of Human Growth Hormone Secretion

16 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Insulin tolerance test in depression.

16 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Cerebrospinal fluid norepinephrine in affective illness

16 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

α adrenoreceptors but not β adrenoreceptors increase in rabbit uterus with oestrogen

16 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Human growth hormone response to levodopa. Relation to menopause, depression, and plasma dopa concentration

16 September 2023

36

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Dextroamphetamine and cortisol in depression. Morning plasma cortisol levels suppressed

16 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Growth hormone and prolactin in unipolar and bipolar depressed patients: responses to hypoglycemia and L-dopa

16 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

The catecholamine hypothesis of affective disorders: a review of supporting evidence

16 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites

16 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions

16 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Modulation of receptor mechanisms in the CNS: Hyper-and hyposensitivity to catecholamines

16 September 2023

43

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

3H-catecholamine binding to α-receptors in rat brain: Enhancement by reserpine

16 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Regulation of rabbit myometrial alpha adrenergic receptors by estrogen and progesterone

16 September 2023

46

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

Resting Plasma Catecholamine Concentrations in Patients With Depression and Anxiety

16 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/0165-1781(82)90005-1

16 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6283576%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference